Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival

EBioMedicine

Volumn 2, Issue 6, 2015, Pages 572-582

  Ferrajoli, Alessandra ^a   Ivan, Cristina ^a   Ciccone, Maria ^a   Shimizu, Masayoshi ^a   Kita, Yoshiaki ^a   Ohtsuka, Masahisha ^a   D'Abundo, Lucilla ^a,b   Qiang, Jun ^a,c   Lerner, Susan ^a   Nouraee, Nazila ^a   Rabe, Kari G ^d   Rassenti, Laura Z ^e   Van Roosbroeck, Katrien ^a   Manning, John T ^a   Yuan, Yuan ^a,f   Zhang, Xinna ^a   Shanafelt, Tait D ^d   Wierda, William G ^a   Sabbioni, Silvia ^b   Tarrand, Jeffrey J ^a   Estrov, Zeev ^a   Radovich, Milan ^a,g   Liang, Han ^g   Negrini, Massimo ^b   Kipps, Thomas J ^e   Kay, Neil E ^d   Keating, Michael ^a   Calin, George A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d Mayo Clinic College of Medicine   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BHRF1 1; Chronic lymphocytic leukemia; Epstein Barr Virus; MiRNAs; Overall survival

Indexed keywords

BETA 2 MICROGLOBULIN; MICRORNA; PROTEIN P53; VIRUS PROTEIN; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN-BARR VIRUS ENCODED RNA 1; MATRIX PROTEIN; TP53 PROTEIN, HUMAN; VIRUS RNA;

ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER CELL; CELL TRANSFORMATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; RNA SEQUENCE; WESTERN BLOTTING; BLOOD; DISEASE FREE SURVIVAL; GENETICS; MORTALITY; TUMOR CELL CULTURE; VIROLOGY;

BETA 2-MICROGLOBULIN; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICRORNAS; RNA, VIRAL; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 84949623255     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.04.018     Document Type: Article

References (39)

1. Amoroso R., Fitzsimmons L., Thomas W.A., Kelly G.L., Rowe M., Bell A.I. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J. Virol. 2011, 85(2):996-1010. (Jan, PubMed PMID: 21068248. Pubmed Central PMCID: 3020024).
2. Arrand J.R., Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 1982, 41(2):376-389. (Feb, PubMed PMID: 6281455. Pubmed Central PMCID: 256768).
3. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., et al. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008, 36(2):666-675. (Feb, PubMed PMID: 18073197. Pubmed Central PMCID: 2241876).
4. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55(4):611-622. (Apr, PubMed PMID: 19246619).
5. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2(3). (Mar, PubMed PMID: 16557291. Pubmed Central PMCID: 1409806).
6. Calin G.A., Croce C.M. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 2009, 114(23):4761-4770. (Nov 26, PubMed PMID: 19745066. Pubmed Central PMCID: 2786287).
7. Campo E., Swerdlow S.H., Harris N.L., Pileri S., Stein H., Jaffe E.S. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011, 117(19):5019-5032. (May 12, PubMed PMID: 21300984. Pubmed Central PMCID: 3109529).
8. Choy E.Y., Siu K.L., Kok K.H., Lung R.W., Tsang C.M., To K.F., et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 2008, 205(11):2551-2560. (Oct 27, PubMed PMID: 18838543. Pubmed Central PMCID: 2571930).
9. Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., Calin G.A. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8(8):467-477. (Aug, PubMed PMID: 21647195. Pubmed Central PMCID: 3423224).
10. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 2003, 348(18):1764-1775. (May 1, PubMed PMID: 12724482).
11. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94(6):1840-1847. (Sep 15, PubMed PMID: 10477712).
12. Delecluse H.J., Feederle R., O'Sullivan B., Taniere P. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 2007, 60(12):1358-1364. (Dec, PubMed PMID: 17873116. Pubmed Central PMCID: 2095566).
13. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 2000, 343(26):1910-1916. (Dec 28, PubMed PMID: 11136261).
14. Dolken L., Malterer G., Erhard F., Kothe S., Friedel C.C., Suffert G., et al. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010, 7(4):324-334. (Apr 22, PubMed PMID: 20413099).
15. Fabbri M., Croce C.M. Role of microRNAs in lymphoid biology and disease. Curr. Opin. Hematol. 2011, 18(4):266-272. (Jul, PubMed PMID: 21519241. Pubmed Central PMCID: 3400499).
16. Fabbri M., Bottoni A., Shimizu M., Spizzo R., Nicoloso M.S., Rossi S., et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011, 305(1):59-67. (Jan 5, PubMed PMID: 21205967. Pubmed Central PMCID: 3690301).
17. Ferrajoli A., Shanafelt T.D., Ivan C., Shimizu M., Rabe K.G., Nouraee N., et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood 2013, 122(11):1891-1899. (Sep 12, PubMed PMID: 23821659. Pubmed Central PMCID: 37793810).
18. Ghosh A.K., Secreto C.R., Knox T.R., Ding W., Mukhopadhyay D., Kay N.E. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 2010, 115(9):1755-1764. (Mar 4, PubMed PMID: 20018914. Pubmed Central PMCID: 2832808).
19. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94(6):1848-1854. (Sep 15, PubMed PMID: 10477713).
20. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Finn T., Young L.S., et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood 1991, 78(10):2666-2673. (Nov 15, PubMed PMID: 1668608).
21. Jochum S., Ruiss R., Moosmann A., Hammerschmidt W., Zeidler R. RNAs in Epstein-Barr virions control early steps of infection. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(21):E1396-E1404. (May 22, PubMed PMID: 22543160. Pubmed Central PMCID: 3361417).
22. Lerner M.R., Andrews N.C., Miller G., Steitz J.A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 1981, 78(2):805-809. (Feb, PubMed PMID: 6262773. Pubmed Central PMCID: 319891).
23. Li Z., Chen X., Li L., Liu S., Yang L., Ma X., et al. EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma. Int. J. Biochem. Cell Biol. 2012, 44:275-279.
24. Linnstaedt S.D., Gottwein E., Skalsky R.L., Luftig M.A., Cullen B.R. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 2010, 84(22):11670-11678. (Nov, PubMed PMID: 20844043. Pubmed Central PMCID: 2977875).
25. Lo A.K., To K.F., Lo K.W., Lung R.W., Hui J.W., Liao G., et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(41):16164-16169. (Oct 9, PubMed PMID: 17911266. Pubmed Central PMCID: 2042179).
26. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 2008, 82(21):10436-10443. (Nov, PubMed PMID: 18753206. Pubmed Central PMCID: 2573162).
27. Lung R.W., Tong J.H., Sung Y.M., Leung P.S., Ng D.C., Chau S.L., et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11(11):1174-1184. (Nov, PubMed PMID: 19881953. Pubmed Central PMCID: 2767219).
28. Marquitz A.R., Mathur A., Nam C.S., Raab-Traub N. The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011, 412(2):392-400. (Apr 10, PubMed PMID: 21333317. Pubmed Central PMCID: 3340891).
29. Navarro A., Gaya A., Martinez A., Urbano-Ispizua A., Pons A., Balague O., et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008, 111(5):2825-2832. (Mar 1, PubMed PMID: 18089852).
30. Nishimura M., Jung E.J., Shah M.Y., Lu C., Spizzo R., Shimizu M., et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013, 3(11):1302-1315. (Sep 3. PubMed PMID: 24002999).
31. Ouyang Q., Wagner W.M., Walter S., Muller C.A., Wikby A., Aubert G., et al. An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech. Ageing Dev. 2003, 124(4):477-485. (Apr, PubMed PMID: 12714256).
32. Pritchard C.C., Kroh E., Wood B., Arroyo J.D., Dougherty K.J., Miyaji M.M., et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev. Res. 2012, 5(3):492-497. (Mar, PubMed PMID: 22158052).
33. Rickinson A.B. Epstein-Barr virus. Field Virology 2001, 2575-2627. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin, M.A. Martin, R.A. Lamb, B. Roizman (Eds.).
34. Rossi S., Shimizu M., Barbarotto E., Nicoloso M.S., Dimitri F., Sampath D., et al. MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 2010, 116(6):945-952. (Aug 12, PMID: 20393129).
35. Tarrand J.J., Keating M.J., Tsimberidou A.M., O'Brien S., LaSala R.P., Han X.Y., et al. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer 2010, 116(4):880-887. (Feb 15, PubMed PMID: 20052729).
36. Tsimberidou A.M., Keating M.J., Bueso-Ramos C.E., Kurzrock R. Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study. Leuk. Lymphoma 2006, 47(5):827-836. (May, PubMed PMID: 16753866).
37. Vasilescu C., Rossi S., Shimizu M., Tudor S., Veronese A., Ferracin M., et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009, 4(10). (PubMed PMID: 19823581. Pubmed Central PMCID: 2756627).
38. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68(5):1436-1442. (Mar 1, PubMed PMID: 18316607. Pubmed Central PMCID: 2855641).
39. Zuo Z., Calin G.A., de Paula H.M., Medeiros L.J., Fernandez M.H., Shimizu M., et al. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 2011, 118(2):413-415. (Jul 14, PubMed PMID: 21602527. Pubmed Central PMCID: 3293748).